ArticleMolecules (Basel, Switzerland)2022

In Silico Screening of Novel TMPRSS2 Inhibitors for Treatment of COVID-19.

Shuo Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.